JPWO2021235425A1 - - Google Patents
Info
- Publication number
- JPWO2021235425A1 JPWO2021235425A1 JP2022524485A JP2022524485A JPWO2021235425A1 JP WO2021235425 A1 JPWO2021235425 A1 JP WO2021235425A1 JP 2022524485 A JP2022524485 A JP 2022524485A JP 2022524485 A JP2022524485 A JP 2022524485A JP WO2021235425 A1 JPWO2021235425 A1 JP WO2021235425A1
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
- A61K38/13—Cyclosporins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5089—Processes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/5123—Organic compounds, e.g. fats, sugars
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2020088154 | 2020-05-20 | ||
PCT/JP2021/018751 WO2021235425A1 (ja) | 2020-05-20 | 2021-05-18 | 脂質ナノ粒子を含有する粒子及びその製造方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
JPWO2021235425A1 true JPWO2021235425A1 (ja) | 2021-11-25 |
Family
ID=78708467
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2022524485A Pending JPWO2021235425A1 (ja) | 2020-05-20 | 2021-05-18 |
Country Status (7)
Country | Link |
---|---|
US (1) | US20230210767A1 (ja) |
EP (1) | EP4169509A1 (ja) |
JP (1) | JPWO2021235425A1 (ja) |
KR (1) | KR20230005989A (ja) |
CN (1) | CN115666535A (ja) |
CA (1) | CA3183691A1 (ja) |
WO (1) | WO2021235425A1 (ja) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2023178334A1 (en) * | 2022-03-18 | 2023-09-21 | Genentech, Inc. | Nano-suspensions and amorophous solid dispersions of hydrophobic agents and methods of use thereof |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5932993B2 (ja) | 1979-06-25 | 1984-08-13 | 株式会社明電舎 | 多相インバ−タの電圧制御装置 |
JPH08133986A (ja) | 1994-11-02 | 1996-05-28 | Mitsubishi Chem Corp | リポソーム凍結乾燥製剤 |
SK288117B6 (sk) * | 1998-11-20 | 2013-09-03 | Skyepharma Canada Inc. | Rapidly dispersing solid dry therapeutic dosage form |
EP1458361A4 (en) * | 2001-11-20 | 2007-04-25 | Advanced Inhalation Res Inc | COMPOSITIONS FOR DISTRIBUTING PRODUCTS WITH LASTING EFFECT |
JP4228230B2 (ja) | 2004-11-08 | 2009-02-25 | 独立行政法人産業技術総合研究所 | リポソーム懸濁液の製造方法及びリポソームを用いた用途 |
JP4647506B2 (ja) | 2006-01-27 | 2011-03-09 | 株式会社リコー | 粒子特にトナー粒子の製造方法、トナー粒子の製造装置及びトナー |
JP5055154B2 (ja) | 2007-03-20 | 2012-10-24 | 株式会社リコー | トナーの製造方法、トナーの製造装置及びトナー |
MY183615A (en) | 2011-06-17 | 2021-03-03 | Berg Llc | Inhalable pharmaceutical compositions |
JP6971043B2 (ja) * | 2016-03-04 | 2021-11-24 | 株式会社リコー | 微粒子の製造方法 |
JP7105179B2 (ja) | 2018-11-26 | 2022-07-22 | 株式会社トーキン | 基板 |
CN110123634A (zh) * | 2018-02-09 | 2019-08-16 | 株式会社理光 | 颗粒的制造方法,颗粒的制造装置,以及颗粒 |
JP2019137670A (ja) * | 2018-02-09 | 2019-08-22 | 株式会社リコー | 粒子の製造方法、粒子の製造装置、及び粒子 |
JP2020023472A (ja) * | 2018-07-30 | 2020-02-13 | 株式会社リコー | 粒子の製造方法、並びに、それにより製造された粒子及び医薬 |
EP3829644A4 (en) * | 2018-07-30 | 2022-05-04 | Ricoh Company, Ltd. | PROCESS FOR MANUFACTURING PARTICLES AND PARTICLE AND MEDICATION MANUFACTURED BY THE PROCESS |
-
2021
- 2021-05-18 US US17/998,895 patent/US20230210767A1/en active Pending
- 2021-05-18 WO PCT/JP2021/018751 patent/WO2021235425A1/ja unknown
- 2021-05-18 EP EP21808125.5A patent/EP4169509A1/en active Pending
- 2021-05-18 JP JP2022524485A patent/JPWO2021235425A1/ja active Pending
- 2021-05-18 CN CN202180038195.7A patent/CN115666535A/zh active Pending
- 2021-05-18 KR KR1020227042357A patent/KR20230005989A/ko unknown
- 2021-05-18 CA CA3183691A patent/CA3183691A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
EP4169509A1 (en) | 2023-04-26 |
WO2021235425A1 (ja) | 2021-11-25 |
CA3183691A1 (en) | 2021-11-25 |
KR20230005989A (ko) | 2023-01-10 |
CN115666535A (zh) | 2023-01-31 |
US20230210767A1 (en) | 2023-07-06 |
Similar Documents
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20221114 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20240313 |